Dan Worthley owns shares in GenCirq, a synthetic biology company focussed on cancer therapeutics. This work was supported by an NHMRC ideas grant (2020555) awarded to Dan Worthley. Dan Worthley is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback